Georgia Nursing Schools

And the evidence is strong enough to encourage people over the age of 40 years should consume each day as a precaution.

But the findings are expected to trigger fierce debate has been going on about the benefits of taking aspirin, which increases the risk of bleeding in the stomach for one of 1,000 patients per year.

In a study of seven trials involving 25,570 patients, researchers found that cancer deaths among those taking 75 milligrams aspirin doses per day is 21 percent lower during the study and 34 percent lower after five years.

Aspirin protects people from cancer of the stomach and intestines, the study found, with the number of cancer deaths amounted to 54 percent lower after five years among those taking aspirin compared with those who do not.

Peter Rothwell from Oxfford University said despite taking aspirin causes a small risk of bleeding in the stomach, the risk that began “eliminated” by the benefits in reducing cancer risk and the risk of heart attack.

“Guide correctly previously been warned that in healthy people in middle age, the small risk of bleeding on aspirin partially offset the benefits of prevention of stroke and heart attack,” he said.

“But the reduction in deaths from some common cancers are now going to change this balance for many people,” Rothwell said, as quoted by Reuters Health and Science correspondent, Kate Kelland.

Aspirin, which was originally developed by Bayer, is a cheap drug that can be freely bought and used to relieve pain and reduce fever.

Various previous studies have found that taking aspirin can reduce the risk of developing colon cancer or large stomach and said the drug had such effects by blocking the enzyme cyclooxygenase2, which encourage inflammation and breakdown in tumor cells and is found at high levels.

In the Rothwell study, published in The Lancet, researchers found that the risk of death 20 years decreased by 10 percent for patients with prostate cancer, 30 percent for patients with lung cancer, 40 percent for cancer of the stomach or intestine and 60 percent for patients oesophageal cancer in people who take aspirin.

The reduction in pancreatic cancer, stomach and brain death difficult to quantify due to a smaller amount.

But researchers are adding treatment with aspirin during the experiment lasted only an average of between four and eight years, so its impact on the risk of cancer deaths may not represent results that may be achieved in a longer-term treatment.

Peter Elwood, an expert on aspirin from Cardiff University Medical School who was not involved in the study, aspirin describes as “an amazing drug.”

“The risk of bleeding is very small compared with its benefits,” he told reporters. “Yes, well, can not be denied is tragic if a person was taken to hospital and given a transfusion – because there is bleeding in his stomach – but compared to all that we want to prevent

Random Posts

• Kiwi Smoothie for Cholesterol and Triglycerides
• Heart Diseases
• Aerobic Threshold Exercise
• Heart Risk Factors
• 5 Tips to Change Your Life and Your New I See
• Exercise and Leave Can be a Serious Problem For our Health